| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |